Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative MVT-5873 in CA 19-9 Producing GI Cancers
NCT03801915Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2019
- Primary completion
- May 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of MVT-5873 in pancreatic cancer (PC), cholangiocarcinoma (CCA), colorectal cancer (CRC), sponsored by National Cancer Institute. Started Nov 2019; status: completed.
02
Drugs
MVT-5873
03
Conditions
pancreatic cancer (PC)cholangiocarcinoma (CCA)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03801915.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801915.